BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18983143)

  • 21. New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searching.
    Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
    J Chem Inf Model; 2006; 46(2):462-70. PubMed ID: 16562973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An empirical process for the design of high-throughput screening deck filters.
    Pearce BC; Sofia MJ; Good AC; Drexler DM; Stock DA
    J Chem Inf Model; 2006; 46(3):1060-8. PubMed ID: 16711725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ensemble stump classifiers and gene expression signatures in lung cancer.
    Frey L; Edgerton M; Fisher D; Levy S
    Stud Health Technol Inform; 2007; 129(Pt 2):1255-9. PubMed ID: 17911916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D; Fogel GB
    J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of mixture distributions to deconvolute the behavior of "hits" and controls in high-throughput screening data.
    Buxser S; Chapman DL
    Anal Biochem; 2007 Feb; 361(2):197-209. PubMed ID: 17214952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of boosting-based decision tree ensemble classifiers for discrimination of thermophilic and mesophilic proteins].
    Zhang GY; Fang BS
    Sheng Wu Gong Cheng Xue Bao; 2006 Nov; 22(6):1026-31. PubMed ID: 17168331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved statistical methods for hit selection in high-throughput screening.
    Brideau C; Gunter B; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):634-47. PubMed ID: 14711389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative statistical parameter for high-throughput screening assay quality assessment.
    Sui Y; Wu Z
    J Biomol Screen; 2007 Mar; 12(2):229-34. PubMed ID: 17218666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micro- and nanofluidic systems for high-throughput biological screening.
    Hong J; Edel JB; deMello AJ
    Drug Discov Today; 2009 Feb; 14(3-4):134-46. PubMed ID: 18983933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning improves the precision and robustness of high-content screens: using nonlinear multiparametric methods to analyze screening results.
    Horvath P; Wild T; Kutay U; Csucs G
    J Biomol Screen; 2011 Oct; 16(9):1059-67. PubMed ID: 21807964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian model averaging for ligand discovery.
    Angelopoulos N; Hadjiprocopis A; Walkinshaw MD
    J Chem Inf Model; 2009 Jun; 49(6):1547-57. PubMed ID: 19489531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistics and decision making in high-throughput screening.
    Coma I; Herranz J; Martin J
    Methods Mol Biol; 2009; 565():69-106. PubMed ID: 19551358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods.
    Neugebauer A; Hartmann RW; Klein CD
    J Med Chem; 2007 Sep; 50(19):4665-8. PubMed ID: 17705363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical instance-based pruning in ensembles of independent classifiers.
    Hernández-Lobato D; Martínez-Muñoz G; Suárez A
    IEEE Trans Pattern Anal Mach Intell; 2009 Feb; 31(2):364-9. PubMed ID: 19110500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods.
    Grime KH; Bird J; Ferguson D; Riley RJ
    Eur J Pharm Sci; 2009 Feb; 36(2-3):175-91. PubMed ID: 19013237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.